Resource Hub
Here you’ll find insightful articles, webinars, and learning guides.
International IP Masterclass
European Startups & Scaleups in the US Some European startups and scale-ups have the ambition to start and grow in North America, especially the US. Strategic advantages of expansion in the United States Expanding to the United States can offer several strategic advantages such as: Expanding to the U.S. allows European startups and scaleups to…
IP and Investors: What Startups Need to Know
Prepare for investment with the most commonly asked questions investors will have about your IP.
Top 5 IP Considerations for Medical Device Startups
A primer on FTO, Patents, Trade Secrets, Trademarks & Copyright.
Be Investable, Acquirable and Successful: IP for MedTech Startups
Project Medtech Episode 152 | featuring Edward Steakley, Managing Partner at Cognition IP and Devon Campbell, Founder at Prodct.
Cost-Effective Patent Prosecution and Portfolio Management
Whether a result of financial performance, a cyclical market downturn or a global crisis such as the COVID-19 pandemic, at some point, every IP decision maker will have to plan for cost reductions.
Cost-Effective Patent Prosecution & Portfolio Management
Our go-to resource for general counsel or in-house teams hiring outside IP counsel, with valuable strategies to ‘do more with less.’
Developing an In-House Patent Portfolio Program
A resourceful guide for in-house teams to decide what to patent and when, with a proven systematic approach to portfolio planning.
Synvivia
Cognition IP drafted Synvivia’s initial biotech patent application within weeks and conducted a patentability search on new technologies to direct the company’s IP portfolio development.
Rejuvenation Technologies
Rejuvenation Technologies needed several patent applications to be filed with limited resources before a crucial fundraising round. Cognition IP delivered within a matter of weeks before the fundraising milestone. The company has since engaged for freedom-to-operate searches and ongoing portfolio development.
Tradewind BioScience
Tradewind BioScience needed to understand the IP landscape before deciding if time and resources should be dedicated to a new target. Cognition IP prepared a freedom-to-operate opinion which allowed the company to make a more compelling pitch to investors during a critical fundraising round.
